Concepts (152)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Drug Discovery | 5 | 2022 | 324 | 1.070 |
Why?
|
| Polypharmacology | 3 | 2020 | 4 | 0.910 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channels | 1 | 2023 | 32 | 0.880 |
Why?
|
| Gold | 1 | 2022 | 270 | 0.760 |
Why?
|
| Spermatozoa | 1 | 2023 | 315 | 0.750 |
Why?
|
| Mebendazole | 1 | 2016 | 10 | 0.590 |
Why?
|
| TNF Receptor-Associated Factor 2 | 1 | 2016 | 39 | 0.580 |
Why?
|
| Models, Molecular | 2 | 2021 | 1732 | 0.440 |
Why?
|
| ras Proteins | 1 | 2016 | 770 | 0.400 |
Why?
|
| Signal Transduction | 3 | 2023 | 11965 | 0.320 |
Why?
|
| Quantitative Structure-Activity Relationship | 2 | 2016 | 30 | 0.290 |
Why?
|
| RNA, Long Noncoding | 2 | 2023 | 598 | 0.280 |
Why?
|
| Molecular Docking Simulation | 2 | 2016 | 144 | 0.270 |
Why?
|
| Carcinoma, Pancreatic Ductal | 3 | 2023 | 1724 | 0.260 |
Why?
|
| Ligands | 3 | 2016 | 995 | 0.260 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2018 | 4757 | 0.250 |
Why?
|
| RNA, Small Nucleolar | 1 | 2023 | 25 | 0.230 |
Why?
|
| beta-Lactamase Inhibitors | 1 | 2023 | 52 | 0.230 |
Why?
|
| Lipolysis | 1 | 2023 | 108 | 0.220 |
Why?
|
| Kynurenine | 1 | 2023 | 71 | 0.220 |
Why?
|
| Smad Proteins | 1 | 2023 | 88 | 0.220 |
Why?
|
| Contraceptive Agents, Male | 1 | 2022 | 20 | 0.210 |
Why?
|
| Enzyme Activation | 2 | 2022 | 1764 | 0.210 |
Why?
|
| Phenylalanine Hydroxylase | 1 | 2021 | 25 | 0.200 |
Why?
|
| Phenylketonurias | 1 | 2021 | 23 | 0.200 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2022 | 243 | 0.200 |
Why?
|
| Antineoplastic Agents | 3 | 2023 | 14289 | 0.200 |
Why?
|
| Phenylalanine | 1 | 2021 | 142 | 0.200 |
Why?
|
| Muscular Atrophy | 1 | 2021 | 105 | 0.190 |
Why?
|
| Small Molecule Libraries | 1 | 2022 | 169 | 0.190 |
Why?
|
| DNA | 3 | 2023 | 2693 | 0.190 |
Why?
|
| Protease Inhibitors | 1 | 2021 | 210 | 0.180 |
Why?
|
| CLOCK Proteins | 1 | 2020 | 35 | 0.180 |
Why?
|
| ARNTL Transcription Factors | 1 | 2020 | 57 | 0.180 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2020 | 161 | 0.180 |
Why?
|
| Pinocytosis | 1 | 2019 | 28 | 0.170 |
Why?
|
| Syndecan-1 | 1 | 2019 | 52 | 0.170 |
Why?
|
| Endometrium | 1 | 2023 | 470 | 0.170 |
Why?
|
| Pancreatic Neoplasms | 3 | 2023 | 5061 | 0.170 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2022 | 521 | 0.160 |
Why?
|
| Uterus | 1 | 2023 | 678 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2023 | 1493 | 0.150 |
Why?
|
| Glioblastoma | 2 | 2020 | 1797 | 0.150 |
Why?
|
| Wnt-5a Protein | 1 | 2016 | 45 | 0.150 |
Why?
|
| Glycoproteins | 1 | 2020 | 747 | 0.140 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2016 | 289 | 0.140 |
Why?
|
| Binding Sites | 2 | 2018 | 2171 | 0.130 |
Why?
|
| Pharmacology | 1 | 2014 | 11 | 0.130 |
Why?
|
| Drug Design | 1 | 2017 | 375 | 0.120 |
Why?
|
| Exons | 1 | 2018 | 1328 | 0.120 |
Why?
|
| Humans | 18 | 2023 | 261506 | 0.120 |
Why?
|
| Computational Biology | 2 | 2020 | 1271 | 0.120 |
Why?
|
| Dasatinib | 1 | 2016 | 862 | 0.110 |
Why?
|
| Anti-Bacterial Agents | 1 | 2023 | 2992 | 0.100 |
Why?
|
| Nuclear Proteins | 1 | 2022 | 3343 | 0.100 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2023 | 2390 | 0.090 |
Why?
|
| Models, Theoretical | 1 | 2014 | 785 | 0.090 |
Why?
|
| Structure-Activity Relationship | 2 | 2022 | 931 | 0.090 |
Why?
|
| ErbB Receptors | 1 | 2018 | 2295 | 0.090 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2020 | 5178 | 0.090 |
Why?
|
| Software | 1 | 2016 | 1321 | 0.080 |
Why?
|
| Neoplasm Invasiveness | 1 | 2016 | 3981 | 0.080 |
Why?
|
| Receptor, ErbB-2 | 1 | 2018 | 2518 | 0.080 |
Why?
|
| MicroRNAs | 1 | 2021 | 2947 | 0.080 |
Why?
|
| Mice | 7 | 2023 | 34495 | 0.080 |
Why?
|
| Animals | 9 | 2023 | 59536 | 0.080 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 6009 | 0.070 |
Why?
|
| Protein Binding | 2 | 2021 | 3438 | 0.060 |
Why?
|
| beta-Lactams | 1 | 2023 | 53 | 0.060 |
Why?
|
| Penicillins | 1 | 2023 | 143 | 0.060 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type II | 1 | 2023 | 19 | 0.060 |
Why?
|
| Rejuvenation | 1 | 2023 | 72 | 0.050 |
Why?
|
| Cell Line, Tumor | 3 | 2023 | 14551 | 0.050 |
Why?
|
| Gene Library | 1 | 2023 | 294 | 0.050 |
Why?
|
| Interleukin-15 | 1 | 2023 | 185 | 0.050 |
Why?
|
| Acetylgalactosamine | 1 | 2021 | 18 | 0.050 |
Why?
|
| Peptide Initiation Factors | 1 | 2021 | 45 | 0.050 |
Why?
|
| Male | 5 | 2023 | 123000 | 0.050 |
Why?
|
| Protein Stability | 1 | 2023 | 370 | 0.050 |
Why?
|
| beta-Lactamases | 1 | 2023 | 179 | 0.050 |
Why?
|
| Myeloid Cell Leukemia Sequence 1 Protein | 1 | 2023 | 275 | 0.050 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2023 | 216 | 0.050 |
Why?
|
| Molecular Conformation | 1 | 2021 | 171 | 0.050 |
Why?
|
| Adipocytes | 1 | 2023 | 305 | 0.050 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2021 | 116 | 0.050 |
Why?
|
| Protein Domains | 1 | 2022 | 314 | 0.050 |
Why?
|
| Tumor Microenvironment | 2 | 2023 | 2864 | 0.050 |
Why?
|
| Epithelium | 1 | 2023 | 720 | 0.050 |
Why?
|
| Nucleic Acid Conformation | 1 | 2021 | 279 | 0.050 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2023 | 994 | 0.050 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2018 | 5319 | 0.050 |
Why?
|
| Molecular Structure | 1 | 2021 | 515 | 0.050 |
Why?
|
| RNA Stability | 1 | 2020 | 125 | 0.050 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2023 | 621 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2023 | 8873 | 0.040 |
Why?
|
| Cell Self Renewal | 1 | 2020 | 62 | 0.040 |
Why?
|
| Genetic Engineering | 1 | 2021 | 288 | 0.040 |
Why?
|
| ADP-Ribosylation Factors | 1 | 2019 | 32 | 0.040 |
Why?
|
| Hepatocytes | 1 | 2021 | 351 | 0.040 |
Why?
|
| Methylation | 1 | 2020 | 597 | 0.040 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2020 | 209 | 0.040 |
Why?
|
| Microglia | 1 | 2020 | 164 | 0.040 |
Why?
|
| Cell Proliferation | 2 | 2023 | 7226 | 0.040 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2019 | 159 | 0.040 |
Why?
|
| Virus Replication | 1 | 2021 | 709 | 0.040 |
Why?
|
| Killer Cells, Natural | 1 | 2023 | 904 | 0.040 |
Why?
|
| Immunity, Cellular | 1 | 2020 | 419 | 0.040 |
Why?
|
| Homeostasis | 1 | 2023 | 950 | 0.040 |
Why?
|
| Heterografts | 1 | 2020 | 733 | 0.040 |
Why?
|
| Mutagenesis, Insertional | 1 | 2018 | 218 | 0.040 |
Why?
|
| PAX6 Transcription Factor | 1 | 2016 | 53 | 0.040 |
Why?
|
| Arginine | 1 | 2020 | 500 | 0.040 |
Why?
|
| Drug Repositioning | 1 | 2017 | 54 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2021 | 7222 | 0.040 |
Why?
|
| Drug Industry | 1 | 2017 | 88 | 0.040 |
Why?
|
| Lung Neoplasms | 1 | 2018 | 11538 | 0.030 |
Why?
|
| Epigenomics | 1 | 2016 | 266 | 0.030 |
Why?
|
| Neural Stem Cells | 1 | 2016 | 181 | 0.030 |
Why?
|
| Databases, Chemical | 1 | 2014 | 3 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2021 | 1270 | 0.030 |
Why?
|
| Diet | 1 | 2021 | 1440 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2021 | 4938 | 0.030 |
Why?
|
| Quinazolines | 1 | 2018 | 923 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2021 | 5637 | 0.030 |
Why?
|
| Repressor Proteins | 1 | 2020 | 1664 | 0.030 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2018 | 973 | 0.030 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2019 | 1331 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2018 | 1987 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2023 | 4078 | 0.030 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2017 | 598 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2020 | 3821 | 0.030 |
Why?
|
| Neoplastic Stem Cells | 1 | 2020 | 1443 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2021 | 5710 | 0.030 |
Why?
|
| Liver | 1 | 2021 | 2961 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 2016 | 1143 | 0.020 |
Why?
|
| Obesity | 1 | 2023 | 2884 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2016 | 1048 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2020 | 6150 | 0.020 |
Why?
|
| Cell Line | 1 | 2018 | 5114 | 0.020 |
Why?
|
| Female | 4 | 2023 | 141928 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2020 | 2330 | 0.020 |
Why?
|
| Internet | 1 | 2014 | 706 | 0.020 |
Why?
|
| Neoplasms | 1 | 2016 | 15193 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2020 | 6942 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2016 | 2054 | 0.020 |
Why?
|
| Apoptosis | 1 | 2023 | 7591 | 0.020 |
Why?
|
| Disease Progression | 1 | 2019 | 6682 | 0.020 |
Why?
|
| Algorithms | 1 | 2017 | 3890 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2016 | 5270 | 0.010 |
Why?
|
| Mutation | 1 | 2018 | 15179 | 0.010 |
Why?
|
| Aged | 1 | 2020 | 70117 | 0.010 |
Why?
|
| Middle Aged | 1 | 2020 | 86204 | 0.010 |
Why?
|